Compare · CONX vs EBAC
CONX vs EBAC
Side-by-side comparison of CONX Corp. (CONX) and European Biotech Acquisition Corp. (EBAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CONX and EBAC operate in Blank Checks (Finance), so they compete in similar markets.
- CONX is the larger of the two at $919.0M, about 5.7x EBAC ($160.7M).
CONX Corp.
CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including the wireless communications industry. The company was incorporated in 2020 and is based in Littleton, Colorado.
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Latest CONX
- SEC Form 10-Q filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- CONX Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- Ergen Charles W converted options into 18,750,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Gst-Exempt Ranch Legacy Trust
- CONX Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- CONX Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Regulation FD Disclosure, Financial Statements and Exhibits
- CONX Corp. Announces Closing of Initial Business Combination
- SEC Form SC 13G/A filed by CONX Corp. (Amendment)
Latest EBAC
- SEC Form 15-12G filed by European Biotech Acquisition Corp.
- SEC Form 25-NSE/A filed by European Biotech Acquisition Corp. (Amendment)
- European Biotech Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form DEFA14A filed by European Biotech Acquisition Corp.
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)